BioSpace News Archive

Press Releases

Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

March 23, 2026
·
6 min read
Press Releases

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

March 23, 2026
·
8 min read
Press Releases

Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial

March 23, 2026
·
6 min read
Press Releases

Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research

March 23, 2026
·
4 min read
Press Releases

NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session

March 23, 2026
·
3 min read
Press Releases

Tempest Therapeutics Announces Up To $6 Million Private Placement

March 23, 2026
·
6 min read
Press Releases

Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering

March 23, 2026
·
4 min read
Press Releases

Cambrex Advances US and European Expansions

March 23, 2026
·
2 min read
Press Releases

Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India

March 23, 2026
·
5 min read
Press Releases

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

March 23, 2026
·
14 min read